AI Insight
Researchers developed CTACIT, a computational toolkit that identifies disease-associated genetic variants by combining DNA sequence conservation data across species with cell type-specific chromatin accessibility patterns. Unlike traditional methods that rely solely on DNA sequence conservation, CTACIT can detect regulatory regions where function is preserved across species even when the exact sequence has changed. When applied to neuropsychiatric disorders, CTACIT identified more disease-relevant genetic variants than existing methods, with experimental validation confirming predictions for variants near the DRD2 gene associated with schizophrenia risk.
Why it matters
This approach addresses a major bottleneck in genetics research by helping scientists pinpoint which genetic variants truly contribute to disease risk among the thousands identified in genome-wide studies. By improving the identification of functional regulatory variants, CTACIT could accelerate the translation of genetic findings into understanding disease mechanisms and developing targeted therapies for neuropsychiatric conditions.
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Measures of nucleotide sequence conservation across species are useful for identifying functional genomic loci, but can fail when regulatory function is maintained, often in a cell type-specific manner, even when sequence is not. We introduce CTACIT, the Cell Type-Aware Conservation Inference Toolkit, to identify trait-associated regulatory variants. CTACIT integrates sequence conservation scores with cell type-specific open chromatin data collected from a few mammalian species to impute function for hundreds more. Applying CTACIT to neuropsychiatric trait loci identifies higher heritability enrichment and more fine-mapped variants than nucleotide conservation and human chromatin data alone. Our in vivo reporter assays validate predictions for enhancers with risk variants near the DRD2 schizophrenia risk locus. By integrating genome conservation and multi-species open chromatin data, CTACIT prioritizes variants within regions of conserved regulatory function for in vivo characterization and addresses a major challenge in translating disease associations to mechanistic understanding.